🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Primary Liver Cancer

Intra-procedural Spectral CT for Image-guided Embolization and Ablation in Interventional Oncology NCT07303725n/a1 site📍 Palo Alto Palo Alto Veterans Institute for Research A Comparative Study of MRI and Ultrasound for Detection of Primary Hepatocellular Carcinoma, Body Composition and Risk Factors for Decompensation in Liver Cirrhosis NCT07291141n/a1 site📍 Linköping Mattias Ekstedt A Simple Breath Test to Detect Liver Cancer and Monitor Liver Conditions NCT06864195n/a1 site📍 London Imperial College London Modified Immune Cells (Autologous Dendritic Cells) and a Vaccine (Prevnar) Combined With Immune Checkpoint Inhibition After High-Dose External Beam Radiation Therapy in Treating Patients With Unresectable Liver Cancer NCT03942328Phase 1, Phase 21 site📍 Rochester Mayo Clinic · Tests: Atezolizumab, Bevacizumab, External Beam Radiation Therapy, Pheresis, Pneumococcal 13-valent Conjugate Vaccine TACE Combined With ICIs Plus MTT After 125I Irradiation Stent Placement in HCC With Main PVTT. NCT06669377n/a1 site📍 Nanjing Zhongda Hospital Intra Artherial Therapies in Treatment of Primary Liver Diseases: an Observational Study NCT06774690n/a1 site📍 Bologna IRCCS Azienda Ospedaliero-Universitaria di Bologna PIN in Combination With Anti-PD1 in Previously Treated Primary Hepatocellular Carcinoma NCT07018518Phase 11 site📍 Beijing Chinese PLA General Hospital · Tests: PIN +anti-PD1 Clinical Trial Evaluating the Safety and Efficacy of Tumor Thermosensitive Embolic Agent in Transcatheter Arterial Chemoembolization for Primary Liver Cancer NCT07356531NA15 sites📍 Hefei📍 Beijing📍 Nanning JIANGSU SHENMING Medical Technology CO., Ltd · Tests: Transcatheter Arterial Chemoembolization MDN-001 Injection for the Treatment of Unresectable Primary Hepatocellular Carcinoma. NCT07391839Phase 18 sites📍 Hefei📍 Fuzhou📍 Guangzhou Suzhou Mednovo Yi Medical Technology Co., Ltd. · Tests: MDN-001 Injection(Yttrium-90 Microsphere Injection) Recurrent Liver Cancer: Reconceptualization and Reevaluation NCT06430983n/a1 site📍 Nanjing Nanjing Medical University The Impact of Emotional Stress on Immunotherapy Outcomes in Liver Cancer Patients: A Multi-Cohort Study NCT07141056n/a5 sites📍 Zhanjiang📍 Guilin📍 Guilin Guilin Medical University, China · Tests: Psychological Stress Status, Psychological Stress Status, Psychological stress status Microwave Ablation for Treatment of Small Renal Tumors and Primary and Secondary Liver Neoplasms NCT03981497n/a1 site📍 Milan Francesco De Cobelli · Tests: Microwave ablation (MWA) Hepatic and Systemic Hemodynamic Modeling During Liver Surgery NCT05339984NA1 site📍 Villejuif Assistance Publique - Hôpitaux de Paris · Tests: Partial hepatectomy (open approach), liver transplantation, Portal vein embolization Transarterial Chemoembolization (TACE) Versus TACE Plus Stereotactic Body Radiation Therapy (SBRT) in Liver Carcinoma NCT03895359Phase 31 site📍 London London Health Sciences Centre Research Institute OR Lawson … · Tests: Stereotactic Body Radiation, Transarterial Chemoembolization Registry of Minimally Invasive Cancer Treatment Using Spectral Angio-CT Image Guidance NCT07636148n/a3 sites📍 Lyon📍 Créteil📍 Leiden Mark C Burgmans, MD PhD An Exploratory Study on Developing an Integrated Approach Combining Multimodal Imaging and Multi-omics Characterization of Tumor Heterogeneity for Precision Diagnosis and Treatment Optimization in Liver Cancer. NCT07101237n/a1 site📍 Beijing Peking Union Medical College Hospital · Tests: Multi-modal ultrasonic imaging system for liver cancer Postoperation Maintenance Therapy for Resectable Liver Metastases of Colorectal Cancer Guided by ctDNA NCT05797077Phase 31 site📍 Guangzhou Sixth Affiliated Hospital, Sun Yat-sen University · Tests: Colorectal resection surgery., FOLFOX chemotherapy regimen, Capecitabine Computer Guided Microwave Liver Ablation NCT07226869NA2 sites📍 Boston📍 Lebanon NE Scientific INC · Tests: Computer-Assisted Microwave Liver Ablation Efficacy and Safety of Multimodal Ablation Combined With PD-1 Monoclonal Antibody, Lenvatinib and TACE in the Treatment of Unresectable Primary Hepatocellular Carcinoma: A Single-Arm, Single-Center Clinical Study NCT06794073NA1 site📍 Shanghai Shanghai Zhongshan Hospital · Tests: Multimodal Thermal Therapy Sapu003 in Advanced mTOR-sensitive Solid Tumors NCT07369505Phase 11 site📍 Adelaide SAPU NANO (US) LLC · Tests: Sapu003, Exemestane 25 MG Liver Embolization Approaches for Tumor Management NCT05714124n/a1 site📍 Milan IRCCS San Raffaele · Tests: Embolization Prospective Clinical Database Construction for Liver Cancer Diagnosis and Treatment NCT07587216n/a1 site📍 Wuhan Tongji Hospital · Tests: liver resection, Systemic therapy combined with locoregional interventions The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas NCT07285044Phase 21 site📍 Jacksonville Mayo Clinic · Tests: Cancer Therapeutic Procedure, Cancer Therapeutic Procedure, Questionnaire Administration Integrated Cancer Repository for Cancer Research NCT02012699n/a42 sites📍 Greenwood Village📍 Manchester📍 Daytona Beach University of Nebraska EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid Tumors NCT07410676Phase 1, Phase 21 site📍 Beijing Essen Biotech · Tests: EBNK-001 + IL-15 + Pembrolizumab Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford NCT01793168n/a2 sites📍 Sioux Falls📍 Sydney Sanford Health Esophageal Varices Prophylaxis in Hepatocellular Carcinoma Treated With Atezolizumab and Bevacizumab NCT06961526NA1 site📍 Tanta Tanta University · Tests: Esophageal band ligation San Raffaele Registry on Liver Cancer NCT07704489n/a1 site📍 Milan IRCCS San Raffaele Ambispective Cohort Study of Precision Medicine for Primary Hepatobiliary Cancer Based on Next-generation Sequencing NCT05520788n/a1 site📍 Wuhan Tongji Hospital · Tests: precise medicine Stereotactic Radiosurgery Versus Radiofrequency Ablation for Primary Liver Cancer NCT06766643Phase 21 site📍 Tianjin Tianjin Medical University Cancer Institute and Hospital · Tests: Stereotactic Body Radiation Therapy (SBRT), Radiofrequency ablation therapy
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy